DUSP1 and neoplasm: Gu et al. used MSC-Exos to effectively inhibit the malignant behavior of HCC tumor stem cells (CSCs) by regulating the C5orf66-AS1/miR-127-3p/DUSP1/ERK pathway, thereby highlighting their therapeutic potential in targeting CSC stemness [131].